Authors

Metoprolol for the prevention of vasovagal syncope

In the Prevention of Syncope Trial, we evaluated whether beta-blocker treatment with metoprolol was beneficial for the treatment of patients with vasovagal syncope. Results showed little evidence that metoprolol was effective in reducing the burden of syncopal symptoms. In a substudy analysis, neither age nor response to isoproterenol was useful in selecting which patients might benefit from metoprolol.

The Core of Compassion in Physician-Assisted Suicide

The practice has only reached a handful of states in 25 years of proposal. What drives the arguments for and against it?

Large-scale clinical epidemiology of stable angina in women and men

We performed a whole-country study using linked health care records in Finland and showed that stable angina as the initial symptomatic manifestation of coronary disease occurs as frequently in women as it does in men. Among easily recognized subgroups, the absolute rates of prognostic outcomes were similarly high in women and men.

Barriers Remain for Better Hepatitis C Virus Care

Treatment initiation was lower among Medicaid and private health insurance recipients aged 18-29 years, compared with patients aged 50-59 years.

AMT Ignorance Doesn't Lead to Tax Bliss

Nurses Are the Center of COVID-19 Crisis Communication. Is Tech Helping?

A deeper look at how nurses are affected during the current health pandemic.

Blend the Money in Your Blended Family

Managing Oral Mucositis in Patients With Cancer

Oral mucositis is a costly consequence of cancer therapy that can impede the efficacy of anticancer therapy. Simple preventive measures can greatly improve the patient�s outcome and quality of life.

Are Tax Credits the Right Tool for You?

Serial biomarker measurements in chronic heart failure

Cardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) have been used to estimate prognosis in heart failure. However, most studies have evaluated decompensated patients using single measurements. To determine the value of serial measurements, we evaluated 190 stable chronic heart failure patients every 3 months during 2 years.